YMAB - Y-mAbs Therapeutics, Inc

Healthcare - Sector
Coverage

YMAB is currently covered by 7 analysts with average potential upside of $11.9 (90.02%) backed by 9 price targets and 31 ratings. Analyst's average stock valuation to be materialised ratio is 30.95% with an average time for price targets to be met of 114 days.

Most recent stock forecast was given by ETZER DAROUT from BMO on 30-Jan-2023.

Highest price target for YMAB is 35, Lowest price target is 4, average price target is 19.5.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

13

$8.32 (177.78%)

27

7 days ago

1/3 (33.33%)

$10.43 (103.64%)

194

Hold

8

$3.32 (70.94%)

8

2 months 4 days ago

0/4 (0%)

$3.93 (63.08%)

Buy

5

$0.32 (6.84%)

56

2 months 4 days ago

2/4 (50%)

$8.97 (30.59%)

25

Hold

6

$1.32 (28.21%)

52

3 months 6 days ago

2/6 (33.33%)

$16.11 (58.16%)

143

Buy

19

$14.32 (305.98%)

63

3 months 6 days ago

1/4 (25%)

$27.94 (287.23%)

403

Show more analysts